|Previous Section||Index||Home Page|
|2003( 1)||2004( 1)||2005( 1)||2003( 2)||2004( 2)||2005( 2)|
|(1) From 2003 data were also weighted for non-response. Data weighted for child selection only are provided for consistency with previous years.|
The Health Survey for England: Uprating of tend tables to include 2005 data. The information Centre.
Mr. Laurence Robertson: To ask the Secretary of State for Health whether she intends patient and public involvement forum members to become members of local involvement networks; and if she will make a statement. 
Ms Rosie Winterton: While we are strongly encouraging forum members to become involved in the new local involvement networks (LINks), we do not wish to prescribe that they should automatically become members because we want all aspects of the arrangements for LINks to be locally determined. It will be a matter for each LINk and Host to consider how best to attract members and involve all people, especially those with experience and knowledge of patient and public involvement.
Mr. Laurence Robertson: To ask the Secretary of State for Health whether the money provided by her Department to county councils for the purpose of establishing and supporting local involvement networks will be ring-fenced; and if she will make a statement. 
Ms Rosie Winterton: It is Government policy to devolve power to local authorities, which will make decisions on priorities according to local needs. For this reason we will not be ring-fencing the funds made available for local involvement networks (LINks), but will be making a targeted grant to each local authority with social services responsibility for the purpose of supporting LINk activities.
Mr. Laurence Robertson: To ask the Secretary of State for Health whether local involvement networks will have a right of entry and access in order to carry out inspections; and if she will make a statement. 
Ms Rosie Winterton: It is our intention to give local involvement networks a right of entry to health and social care facilities to enable them to carry out their activities. Clause 175 of the Local Government and Public Involvement in Health Bill, which is currently before Parliament, sets out the duties services-providers will be under to allow entry by local involvement networks.
Mr. Laurence Robertson: To ask the Secretary of State for Health if she will issue national guidance on how members should be appointed to local involvement networks; and if she will make a statement. 
Ms Rosie Winterton: We are clear that LINks must be able to be flexible and reflect the nature of local communities. Therefore we do not wish to centrally prescribe details on membership. However we do think it is important to provide models of good practice in terms of recruitment, support and conduct of those involved in LINk activity. These will be set out in guidance in due course.
Mrs. Dean: To ask the Secretary of State for Health what research she has (a) commissioned and (b) evaluated on the effect on people diagnosed with photosensitivity of (i) low energy light bulbs and (ii) incandescent light bulbs; and what assessment she has made of the implications of a ban on the latter for people with photosensitivity. 
Caroline Flint: The Department has not commissioned work of this specific nature. There are no firm proposals to ban such light bulbs and it would clearly be necessary to engage the various interested Government Departments, regulatory agencies and advisory bodies in the event of such a ban being considered.
Mr. Clelland: To ask the Secretary of State for Health what progress has been made by the NHS in making available National Institute of Health and Clinical Excellence approved treatments for prostate cancer. 
Ms Rosie Winterton: In June 2006, the National Institute for Health and Clinical Excellence (NICE) published guidance for the national health service on the use of docetaxel for the treatment of prostate cancer. NICE recommended the use of this treatment for particular groups of patients.
NICE technology appraisals are covered by a three-month funding direction. PCTs have a legal obligation to provide funding for treatments recommended by NICE within three months of the guidance being issued.
NICE guidance is also included in Standards for Better Health, which sets out the Governments high-level expectations for the health service. Adherence to NICE technology appraisals is one of the core standards against which NHS organisations are assessed in the Healthcare Commissions annual health check.
In July 2006, Professor Mike Richards, the National Cancer Director, published a review report examining the uptake of NICE approved cancer drugs. Although the report did not include docetaxel for prostate cancer as its guidance had only just been finalised, the report found that approval of a cancer drug by NICE led to increased use of that drug by the NHS and a reduction in variation in use.
Anne Main: To ask the Secretary of State for Health what plans she has to introduce human papilloma virus immunisation for females aged 12 years and above in England; and if she will make a statement. 
Caroline Flint: The Joint Committee on Vaccination and Immunisation (JCVI) is in the process of thoroughly examining the vaccine safety, efficacy and cost-effectiveness evidence concerning human papilloma virus vaccines. The work is being taken forward by a sub-group of JCVI, with further work ongoing to evaluate whether the vaccine is considered to be a cost-effective prevention of cervical cancer; and the impact that HPV vaccine may have on genital warts.
Andrew George: To ask the Secretary of State for Health which (a) primary care trusts and (b) local authorities in England provided services for adults with (i) low and (ii) moderate social care needs in each year since 2001. 
Caroline Flint: Toxocara is not a notifiable disease in England and Wales, therefore the numbers of cases per year is taken from confirmed diagnostic laboratory reports. The Health Protection Agency received 19 laboratory reports in 1998 and fewer than 10 reports in each of the years since then. The breakdown of data by primary care trust area is not collected.
Ms Rosie Winterton:
The table shows the number of people placed onto the organ transplant list at any time
during each of the last 10 years and those on the list at the end of each of the relevant calendar years.
|On list anytime during the year||On list at end of year|